Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$717,934
+$18,187 QoQ
Shares Held
4,581
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#740
of 1,603 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. NVS ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
100,877 | $25,619,731 | |
| 2 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 3 | ABBV |
AbbVie Inc.
|
46,722 | $11,757,124 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,121 | $7,340,048 | |
| 5 | AZN |
Astrazeneca PLC
|
37,843 | $7,175,789 | |
| 6 | AMGN |
Amgen Inc
|
5,635 | $2,040,546 | |
| 7 | NVO |
Novo Nordisk A S
|
23,000 | $1,102,620 | |
| 8 | NVS |
Novartis AG
This page
|
4,581 | $717,934 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $717,934 | 4,581 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $699,747 | 4,581 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $651,711 | 4,727 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $593,366 | 4,627 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $559,913 | 4,627 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $515,817 | 4,627 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $450,253 | 4,627 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $532,197 | 4,627 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $492,590 | 4,627 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $447,569 | 4,627 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $440,330 | 4,361 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $444,211 | 4,361 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $440,068 | 4,361 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $527,620 | 5,735 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $529,351 | 5,835 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $472,402 | 6,215 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $525,353 | 6,215 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $545,805 | 6,220 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $533,129 | 6,095 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $477,186 | 5,835 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $532,385 | 5,835 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $442,102 | 5,172 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $474,699 | 5,027 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $207,138 | 2,382 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||